<DOC>
	<DOCNO>NCT00203502</DOCNO>
	<brief_summary>The main purpose study find effect take drug bevacizumab together two chemotherapeutic agent , docetaxel cyclophosphamide follow doxorubicin alone surgery breast cancer . Bevacizumab give twelve week combination chemotherapy ill hold administration doxorubicin . Twenty-eight fifty-six day undergo surgery , patient receive nine three-weekly infusion bevacizumab .</brief_summary>
	<brief_title>Primary Systemic Therapy Operable/Locally Advanced Breast Cancer</brief_title>
	<detailed_description>Prior enrol study , undergo evaluation determine eligibility . The study doctor obtain complete medical history , complete physical examination include blood pressure heart rate . The doctor also obtain baseline ECG well blood test ( approximately two tablespoon blood ) . In order decrease effect food , exercise sleep/wake cycle variability , blood sample must take 8AM - 10AM patient need fast ( food drink ) 10 hour prior blood test . Patients also need strain work prior blood test . The study ask list current medication . Patients eligible history require long-term anticoagulant ( blood thinner ) therapy ( i.e . Coumadin anything patient may take prevent blood clot ) allergy bevacizumab drug use study . Many follow evaluation commonly do determine diagnosis and/or stage breast cancer may already do . If following procedure do within three week , need do prior receive study therapy . - Diagnosis breast cancer fine needle aspiration core needle biopsy require entry study . - Clip Placement - clip place tumor core biopsy marker assist surgeon time surgery . - Tumor Clip Placements - caliper similar ruler use measure tumor outside body instead always use ultrasound MRI . - Tumor Ultrasound - non-invasive exam us sound wave produce picture tumor . All study participant treat bevacizumab 15 mg/kg plus docetaxel 75 mg/m2 cyclophosphamide 500 mg/m2 every three week total four treatment . Three week completion part treatment patient start receive doxorubicin 60 mg/m2 every three week total four treatment . All drug give intravenous infusion first day three-week period . Patients come every three week visit physical exam include blood pressure heart rate . Medications list take side effect may experience . Tumor caliper measurement do blood drawn visit . A mammogram MUGA scan do prior surgery . Patients undergo tumor surgery approximately six month treatment . Patients need visit study physician one month surgery another physical examination include blood pressure heart rate , assessment side effect list current medication .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>The diagnosis breast cancer establish biopsy . Normal kidney function Normal LVEF evaluate MUGA Scan &gt; 18 year age Good performance status define ECOG scale 0 1 Consent Women childbearing potential must negative pregnancy test . Use effective mean contraception subject childbearing potential treatment least 3 month thereafter . Peripheral Neuropathy : must &lt; grade 1 Hematologic ( minimal value ) Absolute neutrophil count &gt; 1,500/mm3 Hemoglobin &gt; 8.0 g/dl Platelet count &gt; 100,000/mm3 Hepatic Total bilirubin &lt; ULN AST , ALT , Alkaline Phosphatase must within range Patients locally advance breast cancer skin ulceration Stage IV breast cancer Inflammatory breast cancer Allergy component treatment regimen Women breast feeding Pregnancy refusal use effective contraception Inability comply study and/or followup procedure . Current , recent , planned participation experimental drug study Blood pressure &gt; 150/100 mmHg . Essential hypertension well control anti hypertensive exclusion criterion . unstable angina New York Heart Association Grade II great congestive heart failure history myocardial infarction within 6 month history stroke within 6 month Clinical significant peripheral vascular disease Evidence bleed diathesis coagulopathy Presence central nervous system brain metastasis major surgical procedure , open biopsy , significant traumatic injury within 28 day prior day 0 Minor surgical procedure fine needle aspiration core biopsy within 7 day prior day 0 Pregnant lactate Urine protein : creatinine ratio &gt; 1.0 screen History abdominal fistula , gastrointestinal perforation , intraabdominal abscess within 6 month prior Day 0 Serious , nonhealing wound , ulcer , bone fracture</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Operable Locally advance Breast Cancer</keyword>
</DOC>